Page 28 - 《中国药房》2023年1期
P. 28

的内水相,磷脂双分子膜发挥了延缓药物透过的作用。                                 progress  in  bioconjugation  strategies  for  liposome-
          AB4/siP-c-L 在接近内涵体酸性 pH 条件下(pH5.0~5.5)                   mediated  drug  delivery[J].  Molecules,2020,25(23):
          可更快释药,而在中性 pH 条件下(pH7.4)释药速率最                            5672.
          慢。其原因可能是所使用的脂质材料DOTAP的极性基                           [ 9 ]  NIEBERLER M,REUNING U,REICHART F,et al. Ex‐
                                                                   ploring  the  role  of  RGD-recognizing  integrins  in  cancer
          团三甲基铵在酸性条件下的极化程度增加,该极化的极
                                                                   [J]. Cancers,2017,9(9):116.
          性基团聚集使得磷脂双分子膜混乱程度增加,进而导致
                                                              [10]  JIN Y,TONG D Y,CHEN J N,et al. Overexpression of
          膜 通 透 性 增 加 ,最 终 提 高 了 AB4/siP-c-L 中 AB4 在
                                                                   osteopontin,αvβ3  and  Pim-1  associated  with  prognosti‐
          pH5.0~5.5环境中的跨膜释放速率。                                     cally  important  clinicopathologic  variables  in  non-small
              综上所述,本研究制备的 AB4/siP-c-L 可有效实现                        cell lung cancer[J]. PLoS One,2012,7(10):e48575.
          AB4与基因药物siP的共载,并对LLC细胞具有一定的体                        [11]  刘骏,罗莹,张婧,等. 白头翁皂苷B4长循环脂质体的处
          外靶向性,可为后续AB4/siP-c-L的抗肿瘤研究提供基础。                          方优化与评价[J]. 中国新药杂志,2021,30(16):1524-
          参考文献                                                     1529.
          [ 1 ]  国家药典委员会 . 中华人民共和国药典:一部[S]. 2020              [12]  国家药典委员会 . 中华人民共和国药典:四部[S]. 2020
                                                                   年版.北京:中国医药科技出版社,2020:61.
               年版.北京:中国医药科技出版社,2020:108.
                                                              [13]  陈颖翀,李翔,张婧,等. 硫酸长春新碱脂质体含量测定
          [ 2 ]  袁进,张丽峰,高红伟,等.白头翁皂苷B4药理作用研究
                                                                   及 3 种包封率测定方法的比较[J]. 中国药房,2014,25
               进展[J].中成药,2022,44(7):2229-2233.
                                                                  (37):3504-3507.
          [ 3 ]  狄孟华,李桂凤,李言,等. 白头翁皂苷B4在大鼠体内药
                                                              [14]  LI  X,ZOU  Q,ZHANG  J,et  al.  Self-assembled  dual-
               代动力学规律及肺组织分布[J]. 贵州医科大学学报,
                                                                   targeted epirubicin-hybrid polydopamine nanoparticles for
               2018,43(7):745-749.
                                                                   combined  chemo-photothermal  therapy  of  triple-negative
          [ 4 ]  GHOSH C,LUONG G,SUN Y. A snapshot of the PD-1/
                                                                   breast  cancer[J].  Int  J  Nanomedicine,2020,15:6791-
               PD-L1 pathway[J]. J Cancer,2021,12(9):2735-2746.
                                                                   6811.
          [ 5 ]  GAVRILOV K,SALTZMAN W M. Therapeutic siRNA:
                                                              [15]  O’MAHONY A M,DESGRANGES S,OGIER J,et al. In
               principles,challenges,and strategies[J]. Yale J Biol Med,
                                                                   vitro investigations of the efficacy of cyclodextrin-siRNA
               2012,85(2):187-200.
                                                                   complexes modified with lipid-PEG-Octaarginine:towards
          [ 6 ]  MU X P,ZHANG M,WEI A H,et al. Doxorubicin and
                                                                   a formulation strategy for non-viral neuronal siRNA delivery
               PD-L1  siRNA  co-delivery  with  stem  cell  membrane-  [J]. Pharm Res,2013,30(4):1086-1098.
               coated  polydopamine  nanoparticles  for  the  targeted  che‐  [16]  ZHANG J,LI X,HUANG L. Anticancer activities of phy‐
               moimmunotherapy of PCa bone metastases[J]. Nanoscale,  toconstituents  and  their  liposomal  targeting  strategies
               2021,13(19):8998-9008.                              against  tumor  cells  and  the  microenvironment[J].  Adv
          [ 7 ]  DOWDY S F. Overcoming cellular barriers for RNA thera‐  Drug Deliv Rev,2020,(154/155):245-273.
               peutics[J]. Nature Biotechnology,2017,35(3):222-229.         (收稿日期:2022-05-31  修回日期:2022-12-05)
          [ 8 ]  ALMEIDA  B,NAG  O  K,ROGERS  K  E,et  al.  Recent                                (编辑:林 静)


          



         (上接第17页)
          [20]  SANO O,TSUJITA M,SHIMIZU Y,et al. ABCG1 and        liver X receptor (LXR) modulators based on a 2,4,5,6-
               ABCG4 suppress γ-secretase activity and amyloid β pro‐  tetrahydropyrrolo[3,4-c]pyrazole  core[J].  Bioorg  Med
               duction[J].PLoS One,2016,11(5):e0155400.            Chem Lett,2016,26(20):5044-5050.
          [21]  EDLER M K,JOHNSON C T,AHMED H S,et al. Age,   [24]  BEHL  T,KAUR  I,SEHGAL A,et  al.  The  interplay  of
               sex,and regional differences in scavenger receptor CD36   ABC transporters in Aβ translocation and cholesterol me‐
               in  the  mouse  brain:potential  relevance  to  cerebral  amy‐  tabolism:implicating  their  roles  in  Alzheimer’s  disease
               loid angiopathy and Alzheimer’s disease[J]. J Comp Neu‐  [J]. Mol Neurobiol,2021,58(4):1564-1582.
               rol,2021,529(9):2209-2226.                     [25]  CAO G,BALES K R,DEMATTOS R B,et al. Liver X
          [22]  LIFSHITZ V,WEISS R,LEVY H,et al. Scavenger recep‐  receptor-mediated gene regulation and cholesterol homeo‐
               tor A  deficiency  accelerates  cerebrovascular  amyloidosis   stasis in brain:relevance to Alzheimer’s disease therapeu‐
               in  an  animal  model[J].  J  Mol  Neurosci,2013,50(1):  tics[J]. Curr Alzheimer Res,2007,4(2):179-184.
               198-203.                                                     (收稿日期:2022-07-06  修回日期:2022-11-16)
          [23]  TICE C M,NOTO P B,FAN K Y,et al. Brain penetrant                                  (编辑:唐晓莲)


          · 22 ·    China Pharmacy  2023 Vol. 34  No. 1                                中国药房  2023年第34卷第1期
   23   24   25   26   27   28   29   30   31   32   33